Search

Quest Diagnostics Inc

Suletud

SektorTervishoid

235.5 0.06

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

232

Max

236.07

Põhinäitajad

By Trading Economics

Sissetulek

70M

334M

Müük

148M

3B

P/E

Sektori keskmine

25.201

56.597

Aktsiakasum

3.12

Dividenditootlus

1.39

Kasumimarginaal

10.976

Töötajad

46,000

EBITDA

47M

481M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+7.86% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

1.39%

2.18%

Järgmine tulemuste avaldamine

20. okt 2026

Järgmine dividendimakse kuupäev

21. okt 2026

Järgmine aktsia dividendi kuupäev (ex-date)

6. okt 2026

Turustatistika

By TradingEconomics

Turukapital

3.2B

26B

Eelmine avamishind

235.44

Eelmine sulgemishind

235.5

Uudiste sentiment

By Acuity

15%

85%

12 / 339 Pingereas Healthcare

Quest Diagnostics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. sept 2026, 21:01 UTC

News

Quest Diagnostics shares are lower after announcing a new lab test panel for Apple Health app users, priced at $119.

8. sept 2026, 23:26 UTC

Quest Diagnostics Inc shares are higher in after-market hours, reaching a peak cumulative return of 0.78%. No specific news was identified to explain this movement.

4. sept 2026, 19:36 UTC

Quest Diagnostics shares are lower amid rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve. The stock is below its 20-day moving average.

3. sept 2026, 21:04 UTC

Quest Diagnostics Inc shares are higher in after-market trading, showing notable strength during the session. No specific news was identified to explain the movement.

2. sept 2026, 20:03 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidney testing, contributing to shares trading higher during Wednesday's session.

1. sept 2026, 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

31. aug 2026, 23:26 UTC

Quest Diagnostics Inc is rising in after-market trading, rebounding from three days of declines. Broader market dynamics may be influencing investor sentiment.

28. aug 2026, 19:46 UTC

Quest Diagnostics Inc shares are lower today, continuing a decline since Thursday. Broader market conditions and inflation concerns may be influencing the price action.

27. aug 2026, 23:06 UTC

Quest Diagnostics shares are trading lower in after-market hours. The decline follows three consecutive sessions of gains amid mixed market sentiment.

26. aug 2026, 19:46 UTC

Quest Diagnostics shares are lower today, reflecting broader market trends amid rising consumer prices, as indicated by the recent PCE price index data.

25. aug 2026, 23:42 UTC

Correlated Moves

Quest Diagnostics Inc shares declined in after-market trading, following a similar trend seen in Labcorp Holdings Inc. The stock moved lower since Tuesday's close.

24. aug 2026, 23:36 UTC

Event

Quest Diagnostics announced developments in its Alzheimer’s testing portfolio, with shares trading lower in after-market hours amid broader market volatility.

21. aug 2026, 23:01 UTC

Quest Diagnostics shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month range.

20. aug 2026, 20:01 UTC

Quest Diagnostics Inc is trading higher, continuing its upward trend since Wednesday. The stock reached a session high earlier before pulling back slightly.

19. aug 2026, 23:56 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of four consecutive sessions finishing above their 20-day moving average.

17. aug 2026, 19:46 UTC

Correlated Moves
News

Quest Diagnostics Inc's shares are higher, supported by Zacks Research raising Q3 EPS estimates to $2.82 from $2.79 following strong Q2 results.

12. aug 2026, 19:46 UTC

Quest Diagnostics shares are higher, reflecting broader market gains from positive inflation sentiment. The stock remains above its 20-day moving average.

11. aug 2026, 19:26 UTC

Quest Diagnostics shares are higher today, reflecting a general upward trend since Monday. Investors await upcoming U.S. inflation reports that may impact market sentiment.

10. aug 2026, 23:36 UTC

Quest Diagnostics Inc shares are trading higher in after-market hours, showing notable upward movement despite no specific company news identified.

7. aug 2026, 21:01 UTC

Quest Diagnostics Inc. shares are higher in after-market trading, reflecting strong performance above the 20-day moving average and near the one-month range's upper end.

6. aug 2026, 23:01 UTC

Quest Diagnostics Inc. shares declined in after-market trading, reversing a three-session upward trend. The stock remains above its 20-day moving average.

5. aug 2026, 19:36 UTC

Quest Diagnostics Inc shares are higher amid positive market sentiment and easing inflation concerns related to falling crude oil prices. The stock is near its one-month high.

4. aug 2026, 22:02 UTC

Quest Diagnostics Inc shares declined in after-market trading, despite broader positive market sentiment. No specific news was identified to explain the drop.

3. aug 2026, 19:46 UTC

Quest Diagnostics Inc. shares are lower today, continuing a trend of declines after four consecutive sessions of lower closes. No specific news has been identified.

31. juuli 2026, 20:04 UTC

Correlated Moves

Quest Diagnostics is lower today, reflecting broader declines in the Health Care Services sector, including a drop in Labcorp Holdings.

30. juuli 2026, 23:02 UTC

Quest Diagnostics shares are higher in after-market trading, recovering from an earlier dip. The price remains above its 20-day moving average.

29. juuli 2026, 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

28. juuli 2026, 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

27. juuli 2026, 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

24. juuli 2026, 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

Võrdlus sarnastega

Hinnamuutus

Quest Diagnostics Inc Prognoos

Hinnasiht

By TipRanks

7.86% tõus

12 kuu keskmine prognoos

Keskmine 254 USD  7.86%

Kõrge 265 USD

Madal 245 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Quest Diagnostics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

7

Osta

4

Hoia

0

Müü

Sentiment

By Acuity

12 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat